APA (7th ed.) Citation

B, I., R, G., A, V., AI, C., E, M., R, K., & A, T. (2021). Corrigendum to Myelin Oligodendrocyte Glycoprotein Antibody Associated Central Nervous System Demyelinating Disease: A Tertiary Center Experience From Turkey [Multiple Sclerosis and Related Disorders 44 (2020) 102376]. Multiple sclerosis and related disorders, 48, 102581. https://doi.org/10.1016/j.msard.2020.102581

Chicago Style (17th ed.) Citation

B, Inan, Gocmen R, Vural A, Colpak AI, Meinl E, Karabudak R, and Tuncer A. "Corrigendum to Myelin Oligodendrocyte Glycoprotein Antibody Associated Central Nervous System Demyelinating Disease: A Tertiary Center Experience From Turkey [Multiple Sclerosis and Related Disorders 44 (2020) 102376]." Multiple Sclerosis and Related Disorders 48 (2021): 102581. https://doi.org/10.1016/j.msard.2020.102581.

MLA (9th ed.) Citation

B, Inan, et al. "Corrigendum to Myelin Oligodendrocyte Glycoprotein Antibody Associated Central Nervous System Demyelinating Disease: A Tertiary Center Experience From Turkey [Multiple Sclerosis and Related Disorders 44 (2020) 102376]." Multiple Sclerosis and Related Disorders, vol. 48, 2021, p. 102581, https://doi.org/10.1016/j.msard.2020.102581.